427 related articles for article (PubMed ID: 17184058)
1. [Comparison of two schemes of administering the Russian protamine sulfate after extracorporeal circulation in cardiosurgical patients].
Charnaia MA; Morozov IuA; Gladysheva VG; Isaeva AM
Anesteziol Reanimatol; 2006; (5):31-3. PubMed ID: 17184058
[TBL] [Abstract][Full Text] [Related]
2. Heparin removal after cardiopulmonary bypass in a patient with adverse reaction to protamine.
Tevaearai HT; Jegger D; Mueller XM; Horisberger J; von Segesser LK
Thorac Cardiovasc Surg; 1998 Oct; 46(5):303-4. PubMed ID: 9885123
[TBL] [Abstract][Full Text] [Related]
3. Heparin and protamine titration do not improve haemostasis in cardiac surgical patients.
Shore-Lesserson L; Reich DL; DePerio M
Can J Anaesth; 1998 Jan; 45(1):10-8. PubMed ID: 9466020
[TBL] [Abstract][Full Text] [Related]
4. A comparison of thromboelastography with heparinase or protamine sulfate added in vitro during heparinized cardiopulmonary bypass.
Spiess BD; Wall MH; Gillies BS; Fitch JC; Soltow LO; Chandler WL
Thromb Haemost; 1997 Aug; 78(2):820-6. PubMed ID: 9268178
[TBL] [Abstract][Full Text] [Related]
5. [Impact of protamine sulfate on hemostasis system after operations with artificial circulation].
Charnaia MA; Klypa TV; Morozov IuA; Shmerko NP; Gladysheva VG; Andriianova AA
Khirurgiia (Mosk); 2007; (8):17-20. PubMed ID: 17828120
[TBL] [Abstract][Full Text] [Related]
6. Effect of high or low protamine dosing on postoperative bleeding following heparin anticoagulation in cardiac surgery. A randomised clinical trial.
Meesters MI; Veerhoek D; de Lange F; de Vries JW; de Jong JR; Romijn JW; Kelchtermans H; Huskens D; van der Steeg R; Thomas PW; Burtman DT; van Barneveld LJ; Vonk AB; Boer C
Thromb Haemost; 2016 Aug; 116(2):251-61. PubMed ID: 27277211
[TBL] [Abstract][Full Text] [Related]
7. Administration of clemastine--H1 histamine receptor blocker in the prevention of haemodynamic disorders after protamine sulfate administration in patients subjected to coronary artery bypass grafting in extracorporeal circulation.
Lango R; Mroziński P; Wujtewicz M; Suchorzewska J; Rogowski J; Narkiewicz M; Siebert J
Med Sci Monit; 2000; 6(4):769-75. PubMed ID: 11208407
[TBL] [Abstract][Full Text] [Related]
8. [A method for calculating the additional quantity of protamine sulfate during cardiosurgical operations].
Charnaia MA; Morozov IuA; Gladysheva VG
Klin Lab Diagn; 2007 May; (5):28-9. PubMed ID: 17665617
[TBL] [Abstract][Full Text] [Related]
9. Strategies for improving the functionality of an affinity bioreactor.
Wang T; Yang Z; Emregul E; David A; Balthasar JP; Liang J; Yang VC
Int J Pharm; 2005 Dec; 306(1-2):132-41. PubMed ID: 16246511
[TBL] [Abstract][Full Text] [Related]
10. The effects of protamine overdose on coagulation parameters as measured by the thrombelastograph.
Khan NU; Wayne CK; Barker J; Strang T
Eur J Anaesthesiol; 2010 Jul; 27(7):624-7. PubMed ID: 20485179
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular effects of protamine sulfate in man.
Conahan TJ; Andrews RW; MacVaugh H
Anesth Analg; 1981 Jan; 60(1):33-6. PubMed ID: 6779674
[TBL] [Abstract][Full Text] [Related]
12. Heparin therapy during extracorporeal circulation. II. The use of a dose-response curve to individualize heparin and protamine dosage.
Bull BS; Huse WM; Brauer FS; Korpman RA
J Thorac Cardiovasc Surg; 1975 May; 69(5):685-9. PubMed ID: 1127967
[TBL] [Abstract][Full Text] [Related]
13. Management of postoperative heparin rebound following cardiopulmonary bypass.
Pifarré R; Babka R; Sullivan HJ; Montoya A; Bakhos M; El-Etr A
J Thorac Cardiovasc Surg; 1981 Mar; 81(3):378-81. PubMed ID: 7464201
[TBL] [Abstract][Full Text] [Related]
14. [Heparin-protamine-protocol].
Nomoto S
Nihon Geka Hokan; 1997 May; 66(2):49-50. PubMed ID: 9796248
[No Abstract] [Full Text] [Related]
15. [Catastrophic pulmonary vasoconstriction associated with protamine reversal of heparin].
Cao Y; Shioi K; Narumiya C; Aoyama T; Mase T; Nagata Y
Kyobu Geka; 2000 May; 53(5):390-5. PubMed ID: 10808289
[TBL] [Abstract][Full Text] [Related]
16. Successful use of a reduced dose of protamine after cardiopulmonary bypass.
Guffin AV; Dunbar RW; Kaplan JA; Bland JW
Anesth Analg; 1976; 55(1):110-3. PubMed ID: 1108703
[TBL] [Abstract][Full Text] [Related]
17. [Effectiveness of preventing hypotension with H1/H2 antagonists before protamine administration].
Behne M; Bremerich D; Schiesser S; Asskali F
Infusionsther Transfusionsmed; 1994 Apr; 21(2):81-5. PubMed ID: 7517238
[TBL] [Abstract][Full Text] [Related]
18. [Heparinization control by activated coagulation time in cardiac surgery with extracorporeal circulation].
Daudt CA; Pereira SN; Moraes LB; Costa PS; Deboni LM; Figueiredo MS
Arq Bras Cardiol; 1989 Mar; 52(3):137-9. PubMed ID: 2597000
[TBL] [Abstract][Full Text] [Related]
19. Protamine dosing--the quandary continues.
Hall RI
Can J Anaesth; 1998 Jan; 45(1):1-5. PubMed ID: 9466018
[No Abstract] [Full Text] [Related]
20. Protamine sulfate: crouching clot or hidden hemorrhage?
Nielsen VG; Malayaman SN
Anesth Analg; 2010 Sep; 111(3):593-4. PubMed ID: 20733163
[No Abstract] [Full Text] [Related]
[Next] [New Search]
